Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > LBL currently testing this in three countries to get result

<< Previous

Bullboard Posts

Next >>

Comment by Nomoreshells4meon Apr 23, 2020 1:42pm

111 Views

Post# 30945714

RE: LBL currently testing this in three countries to get result

can't remember where or when I heard it but could be Italy and Australia. Perhaps a group of RRT's in each country will be conducting the trials. Just a guess though. Nobody knows but Guy and he ain't talking.

<< Previous

Bullboard Posts

Next >>

A PGM mining stock with value written all over it